Iceland· IS-MTnr 930056 (IS)

Stamaril

A gelbfieber, lebend abgeschwächt product containing gulusóttarveira 17d-204 stofn (lifandi, veikluð), registered in Iceland by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07BL01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedStamarilATCJ07BL01REGISTER NO.IS-MTnr 930056 (IS)PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Gelbfieber, lebend abgeschwächt is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BL01 (gelbfieber, lebend abgeschwächt), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Gelbfieber, lebend abgeschwächt · ATC J07BL01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Gulusóttarveira 17D-204 stofn (lifandi, veikluð)
Manufacturer
Sanofi Winthrop Industrie
Country
Iceland (IS)
ATC code
J07BL01
ATC class
Gelbfieber, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    453055
    0,5 ml x10 hgl
    ISK 52382
  • ean
    991457
    0,5 ml x1 áfspr
    ISK 17541

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gelbfieber, lebend abgeschwächt in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gelbfieber, lebend abgeschwächt products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Stamaril
  • Belgium · Stamaril
  • Bulgaria · Стамарил
  • Cyprus · Stamaril
  • Czechia · Stamaril
  • Germany · Stamaril
  • Denmark · Stamaril
  • Estonia · Stamaril
  • Spain · Stamaril
  • Finland · Stamaril
  • France · Stamaril
  • United Kingdom (Northern Ireland) · Stamaril
  • Hungary · Stamaril
  • Ireland · Stamaril
  • Italy · Stamaril
  • Lithuania · Stamaril
  • Luxembourg · Stamaril
  • Latvia · Stamaril
  • Malta · Stamaril
  • Netherlands · Stamaril
  • Norway · Stamaril
  • Poland · Stamaril
  • Portugal · Stamaril
  • Romania · Stamaril
  • Sweden · Stamaril
  • Slovakia · Stamaril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5263f513-0efa-4f48-9bea-579e9d1b2285
GET /v1/drugs/5263f513-0efa-4f48-9bea-579e9d1b2285?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyfsstofn og leysir, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "J07BL01",
  "marketed": true,
  "strength": null,
  "ma_number": "MTnr 930056 (IS)",
  "substance": "Gulusóttarveira 17D-204 stofn (lifandi, veikluð)",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "35065"
}

See everything about gelbfieber, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.